Model Developed for Predicting Disease Progression in Hep B Liver Cirrhosis

THURSDAY, April 6, 2023 -- For patients with hepatitis B virus (HBV) liver cirrhosis-acute decompensation (LC-AD), a model combining computed tomography (CT) quantified extracellular liver volume (ECVIC-liver) and chronic liver failure...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news